Basic Information
RNALocate ID: | RLID:11003842 |
RNA Symbol: | hsa-miR-200c-5p |
Localization: | Microvesicle |
RNA Information
RNA Name: | hsa-miR-200c-star |
RNA ID: | miRBase:MIMAT0004657 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23539611 |
Tissue/Cell Line: | Seminal plasma |
Method: | Microarray |
Description: | In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID-D:11001520 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine | |
RLID-D:11004086 | Microvesicle | Cell lines(GBM46|GBM8|HaCaT|K562|MCF-10A|MCF-7|MGG75)|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocytes |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-200c-5p | Large cell neuroendocrine cancer | MNDR-E-MI-26445 |
MNDR | hsa-miR-200c-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-26446 |
MNDR | hsa-miR-200c-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-26447 |
MNDR | hsa-miR-200c-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-26448 |
MNDR | hsa-miR-200c-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-26449 |
MNDR | hsa-miR-200c-5p | Prostate cancer | MNDR-E-MI-26450 |
MNDR | hsa-miR-200c-5p | Gastric cancer | MNDR-E-MI-26451 |
MNDR | hsa-miR-200c-5p | Parkinson disease | MNDR-E-MI-26452 |
MNDR | hsa-miR-200c-5p | Breast cancer | MNDR-E-MI-26453 |
MNDR | hsa-miR-200c-5p | Pituitary neoplasms | MNDR-E-MI-26454 |
MNDR | hsa-miR-200c-5p | Pancreatic cancer | MNDR-E-MI-26455 |
MNDR | hsa-miR-200c-5p | Rectum adenocarcinoma | MNDR-E-MI-26456 |
MNDR | hsa-miR-200c-5p | Colon cancer | MNDR-E-MI-26457 |
MNDR | hsa-miR-200c-5p | Colon adenocarcinoma | MNDR-E-MI-26458 |
MNDR | hsa-miR-200c-5p | Prostate adenocarcinoma | MNDR-E-MI-26459 |
MNDR | hsa-miR-200c-5p | Carcinoma ductal breast | MNDR-E-MI-26460 |
MNDR | hsa-miR-200c-5p | Glioblastoma | MNDR-E-MI-26461 |
MNDR | hsa-miR-200c-5p | Breast carcinoma | MNDR-E-MI-26462 |
MNDR | hsa-miR-200c-5p | Gastric adenocarcinoma | MNDR-E-MI-26463 |
MNDR | hsa-miR-200c-5p | Cervical squamous cell carcinoma | MNDR-E-MI-26464 |
MNDR | hsa-miR-200c-5p | Pituitary adenoma | MNDR-E-MI-26465 |
MNDR | hsa-miR-200c-5p | Lung squamous cell carcinoma | MNDR-E-MI-26466 |
MNDR | hsa-miR-200c-5p | Lung adenocarcinoma | MNDR-E-MI-26467 |
MNDR | hsa-miR-200c-5p | Thyroid carcinoma | MNDR-E-MI-26468 |
MNDR | hsa-miR-200c-5p | Ovarian carcinoma | MNDR-E-MI-26469 |
MNDR | hsa-miR-200c-5p | Bladder urothelial carcinoma | MNDR-E-MI-26470 |
MNDR | hsa-miR-200c-5p | Carcinoma renal cell | MNDR-E-MI-26471 |
MNDR | hsa-miR-200c-5p | Cholangiocarcinoma | MNDR-E-MI-26472 |
MNDR | hsa-miR-200c-5p | Esophageal cancer | MNDR-E-MI-26473 |
MNDR | hsa-miR-200c-5p | Lung small cell carcinoma | MNDR-E-MI-26474 |
MNDR | hsa-miR-200c-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-26475 |
MNDR | hsa-miR-200c-5p | Breast invasive carcinoma | MNDR-E-MI-26476 |
MNDR | hsa-miR-200c-5p | Burkitt lymphoma | MNDR-E-MI-26477 |
MNDR | hsa-miR-200c-5p | Colorectal cancer | MNDR-E-MI-26478 |
MNDR | hsa-miR-200c-5p | Breast cancer her3+ negative | MNDR-E-MI-26479 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | BMI1 | Homo sapiens | RR00226523 |
TOP